Transfer Factor for Treatment of Multiple Sclerosis Form
Procedure is not covered
Transfer factor is the dialysate of an extract from sensitized leukocytes which increases cellular immune activity in the recipient. It is not covered as a treatment for multiple sclerosis because its use for the purpose is still experimental.
Book a walkthrough
Walk through this policy with us
Review how this policy can be converted into cited criteria, prior authorization checks, and operational automation.
Loading available demo times